Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replication of hepatitis C virus.

Darius Moradpour1, François Penin, Charles M Rice

  • 1Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, CH-1011 Lausanne, Switzerland. darius.moradpour@chuv.ch

Nature Reviews. Microbiology
|May 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same author

A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralization.

bioRxiv : the preprint server for biology·2026
Same author

Hepatitis C virus infection dynamics, treatment, and lipid nanoparticle-mediated infection in humanized liver chimeric mouse models.

Science advances·2026
Same author

Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Autoantibodies neutralizing type I IFNs in 40% of patients with WNV encephalitis in seven new cohorts.

Journal of human immunity·2026
Same author

Factor VIII originates primarily from anatomically distinct subsets of liver sinusoidal endothelial cells.

Blood advances·2026
Same journal

Waterborne diseases and climate change.

Nature reviews. Microbiology·2026
Same journal

Climate adaptation and biodiversity shape West Nile virus risk in cities.

Nature reviews. Microbiology·2026
Same journal

Climate factors and evolution drive cholera surges in Dhaka.

Nature reviews. Microbiology·2026
Same journal

Climate change boosts Salmonella antimicrobial resistance.

Nature reviews. Microbiology·2026
Same journal

Reframing risk assessment for malaria elimination in a changing climate.

Nature reviews. Microbiology·2026
Same journal

Bacterial vesicles protect the membrane during polymyxin stress.

Nature reviews. Microbiology·2026
See all related articles

Recent advances in hepatitis C virus (HCV) research, including cell-culture systems, illuminate viral replication. This progress aids in identifying new antiviral targets and therapies for liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) is a global health concern, leading to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
  • Understanding HCV replication is crucial for developing effective treatments.

Purpose of the Study:

  • To summarize recent advancements in understanding hepatitis C virus replication.
  • To highlight the impact of new cell-culture systems on studying the viral lifecycle.
  • To discuss the translation of research findings into novel therapeutic strategies.

Main Methods:

  • Development and utilization of complete cell-culture systems for HCV.
  • Systematic dissection of the viral lifecycle, including early and late replication steps.
  • Identification of novel antiviral targets.

Related Experiment Videos

Main Results:

  • Complete cell-culture systems now facilitate comprehensive study of the entire HCV lifecycle.
  • Insights gained into previously challenging early and late viral replication stages.
  • Identification of new targets for antiviral drug development.

Conclusions:

  • Progress in HCV replication research, driven by cell-culture systems, offers new therapeutic avenues.
  • Novel antiviral strategies are emerging and undergoing clinical evaluation for treating HCV-related liver diseases.